11:46 AM EST - 3D Signatures Inc. : Presented the preliminary results of an important collaborative initiative between the Company and the Institut Universitaire de Cardiologie et de Pneumologie De Quebec (IUCPQ) exploring the possibility of identifying a biological marker to distinguish between two deadly forms of lung cancer, multiple synchronous lung adenocarcinoma (AC) and metastatic lung AC, which is a significant unmet clinical need in the management of patients with multiple lung lesions. 3D Signatures Inc.
shares V.DXD are trading down $0.01 at $0.74.
